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A B S T R A C T
Neural crest cells have broad migratory and diﬀerentiative ability that diﬀers according to their axial level of
origin. However, their transient nature has limited understanding of their stem cell and self-renewal properties.
While an in vitro culture method has made it possible to maintain cranial neural crest cells as self-renewing
multipotent crestospheres (Kerosuo et al., 2015), these same conditions failed to preserve trunk neural crest in a
stem-like state. Here we optimize culture conditions for maintenance of avian trunk crestospheres, comprised of
both neural crest stem and progenitor cells. Our trunk-derived crestospheres are multipotent and display self-
renewal capacity over several weeks. Trunk crestospheres display elevated expression of neural crest cell
markers as compared to those characteristic of ventrolateral neural tube or mesodermal fates. Moreover, trunk
crestospheres express increased levels of trunk neural crest-enriched markers as compared to cranial
crestospheres. Finally, we use lentiviral transduction as a tool to manipulate gene expression in trunk
crestospheres. Taken together, this method enables long-term in vitro maintenance and manipulation of
multipotent trunk neural crest cells in a premigratory stem or early progenitor state. Trunk crestospheres are a
valuable resource for probing mechanisms underlying neural crest stemness and lineage decisions as well as
accompanying diseases.
1. Introduction
The neural crest is a multipotent stem cell population that forms
essential structures of the vertebrate body. Arising within the neuroec-
toderm after gastrulation, premigratory neural crest cells in the dorsal
neural tube express numerous transcription factors including FOXD3,
TFAP2 and SOXE (Khudyakov and Bronner-Fraser, 2009). Around the
time of neural tube closure, neural crest cells delaminate from the
neural tube by undergoing an epithelial-to-mesenchymal transition
(EMT), a feature shared with metastatic cancer cells, and then migrate
extensively to populate distant sites in the embryo. In their ﬁnal sites,
neural crest cells diﬀerentiate into more than thirty diﬀerent cell types,
the range of which varies according to their anterior to posterior axial
level of origin.
Elegant quail-chick grafting experiments (Ayer-Le Lievre and Le
Douarin, 1982) have shown that diﬀerent populations of neural crest
cells arise at diﬀerent levels of the body axis designated from anterior to
posterior as cranial, vagal, trunk and sacral. These four subdivisions all
share the ability to form cells of the peripheral nervous system,
melanocytes and smooth muscle (Bittencourt et al., 2013; Bronner-
Fraser and Fraser, 1988), but also give rise to axial level-speciﬁc
features. For example, facial bone/cartilage arise from cranial neural
crest (Ayer-Le Lievre and Le Douarin, 1982) whereas chromaﬃn cells of
the adrenal medulla only arise from the trunk (Vega-Lopez et al., 2018).
The stem cell properties of neural crest cells make them a cell type
of interest in regenerative medicine as well as a possible cell of origin
for neural crest-derived tumors and birth defects (Vega-Lopez et al.,
2018), highlighting the importance of understanding the regulatory
https://doi.org/10.1016/j.ydbio.2019.01.010
Received 17 August 2018; Received in revised form 9 January 2019; Accepted 9 January 2019
⁎ Corresponding author.
⁎⁎ Corresponding author at: Neural Crest Development and Disease Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health
and Human Services, Bethesda, MD 20892, USA.
E-mail addresses: soﬁe.mohlin@med.lu.se (S. Mohlin), laura.kerosuo@nih.gov (L. Kerosuo).
Developmental Biology 447 (2019) 137–146
Available online 18 January 2019
0012-1606/ Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
MARK
mechanisms underlying neural crest stemness. To address this, we
recently reported establishment of crestospheres for cranial neural
crest cells. These are self-renewing multipotent primary neural crest
cultures derived from either chick embryos or human embryonic stem
cells (Kerosuo et al., 2015). Crestospheres maintain neural crest cells as
premigratory neuroepithelial cells and diﬀer from previous culture
techniques which induce spontaneous diﬀerentiation (Baroﬃo et al.,
1988; Curchoe et al., 2010; Lee et al., 2007; Stemple and Anderson,
1992; Trentin et al., 2004). Under crestosphere conditions, premigra-
tory neural crest cells retain multipotency on a clonal level (Kerosuo
et al., 2015). Given that there are known axial level diﬀerences between
neural crest populations and diﬀerent signaling cascades that deter-
mine the anterior to posterior patterning of the vertebrate body, it is
not surprising that the established cranial crestosphere conditions do
not support maintenance of trunk-derived neural crest cells.
To circumvent this problem, here, we provide a modiﬁed protocol
that enables long term growth of trunk crestospheres as epithelial
spheres under stem cell-promoting culture conditions. We show that
trunk crestospheres in culture are multipotent with the ability to
diﬀerentiate into a wide variety of neural crest-derived lineages
including neuronal, smooth muscle, glia/astrocyte and cartilage. In
addition, these crestospheres possess self-renewal capacity over several
weeks. Trunk-derived crestospheres express general markers of the
premigratory neural crest as well as genes speciﬁc to the trunk level, as
shown by quantitative PCR, in situ hybridization and immunohisto-
chemistry. Importantly, as a useful tool for gene expression manipula-
tion, trunk neural crest-derived crestospheres can be eﬃciently trans-
duced with ﬂuorescently labelled lentiviral vectors. Thus, they hold
great promise as an in vitro model for examining trunk neural crest-
associated birth defects and malignancies such as the childhood tumor
form neuroblastoma and adult tumor forms paraganglioma and
pheochromocytoma.
2. Material and methods
2.1. Chick embryos
Chick embryos were obtained from commercially purchased ferti-
lized eggs and incubated at 37.5 °C/100°F until they reached desired
developmental stages. For trunk cultures, we used stage 13-/14 + (17–
21 somite stage) embryos. For the cranial cultures used as controls,
stage 8-/9 (4–7 somite stage) embryos were used, staged according to
the criteria of Hamburger Hamilton (HH) (Hamburger and Hamilton,
1951). In a few cases, we tested cranial cultures from later stages when
most of the neural crest has already migrated from the neural tube
(i.e. HH10 +).
2.2. Neural tube dissection
Embryos at designated somite stages were collected from the eggs
by using Whatman ﬁlter paper. Embryos were placed in the center and
transferred to Ringer's balanced salt solution (Solution-1: 144 g NaCl,
4.5 g CaCl·2H2O, 7.4 g KCl, ddH2O to 500ml; Solution-2: 4.35 g
Na2HPO4·7H2O, 0.4 g KH2PO4, ddH2O to 500ml (adjust ﬁnal pH to
7.4)). Embryos were detached from the ﬁlter paper and placed ventral
side up to cut out the endoderm by “cutting from the ventral midline”.
Neural tubes from respective axial levels were carefully dissected out,
and all neighboring mesoderm and notochord tissue was removed.
Isolated neural tubes were transferred to a small volume (50 μl) of
sterile PBS on ice. For cranial-derived cultures used as controls, the
very anterior tip was excluded, and the neural tube was dissected until
the ﬁrst somite level as previously described (Kerosuo et al., 2015). For
trunk-derived cultures, the neural tube was dissected between somites
10–15, and neighboring somites were removed to highest degree
possible. Pools of neural tubes from 4 to 6 embryos were used for
each culture.
2.3. Cell culture
Pooled neural tubes were mechanically dissociated (~ 30 times until
clumps of ~ 50–100 cells were formed) and transferred to NC medium
(DMEM with 4.5 g/L glucose, 7.5% chick embryo extract, 1X B27, basic
ﬁbroblast growth factor (bFGF, 20 ng/ml), insulin growth factor -I
(IGF-I, 20 ng/ml), retinoic acid (RA; 60 nM for cranial and 180 nM for
trunk, respectively), and with or without 25 ng/ml BMP-4 in low-
adherence T25 tissue culture ﬂasks (2ml (cranial) or 1.5 ml (trunk) per
ﬂask in upright position)). See Table 1 for complete culture conditions.
During the course of 7–14 days, the total volume of media was
incrementally increased to a maximum of Vtot = 10ml. Due to rapid
degradation, retinoic acid and BMP-4 were re-added to the culture
medium volume every 2–3 days, and the spheres were also gently
dispersed by pipetting up and down ~ 10–20 times against the culture
ﬂask wall every 2–3 days.
2.4. RNA extraction and quantitative real-time PCR
Total RNAwas extracted using the RNAqueousMicro Kit (Ambion) and
eluted in 20μl elution solution. cDNA synthesis using random primers and
qRT-PCR was performed as previously described (Mohlin et al., 2015).
Relative mRNA levels were normalized to expression of two reference genes
(18S, 28S) using the comparative Ct method (Vandesompele et al., 2002).
See Supplementary Table 1 for primer sequences.
2.5. Whole mount in situ hybridization of embryos and crestospheres
For whole mount in situ hybridization, embryos were ﬁxed over-
night in 4% paraformaldehyde (PFA) at + 4 °C, washed in PBS
containing 0.1% Tween 20 with 0.1% DEPC (DEPC-PBT), dehydrated
in a methanol (MeOH)/PBT series at room temperature and kept in
100% MeOH at −20 °C until use. In situ hybridization was performed
as previously described (Acloque et al., 2008); brieﬂy, embryos were
rehydrated back to 100% PBT and prehybridized in hybridization
buﬀer for 2 h at 70 °C. Embryos were then hybridized with
Digoxigenin (DIG)-labelled probes overnight at 70 °C. The next day,
embryos were washed in prehybridization buﬀer multiple times
before switching to Maleic Acid Buﬀer (MAB) with 0.1% Tween
20 (MABT). Embryos were then blocked in MABT solution with 10%
Boehringer Blocking Reagent and 10% Sheep Serum for 2 h and incubated
with an anti-DIG antibody (1:2000) (Roche) in blocking solution
overnight at 4 °C. On day 3, embryos were washed in MABT throughout
the day and then switched into Alkaline phosphatase buﬀer (NTMT;
100mM NaCl, 100mM Tris-Cl (pH 9.5), 50mM MgCl2, 1%Tween-20)
before visualizing the signal using nitroblue tetrazolium (NBT) and
Table 1
Culture medium optimized for trunk crestospheres.
Medium (NC) CFinal
DMEM (with P/S)
Chicken embryo extract 7.5%
B27 1 ×
IGF-I 20 ng/ml
FGF 20 ng/ml
Retinoic Acid 180 nM
BMP-4 25 ng/ml
DMEM Corning #10-013-CVR, with 4.5 g/L Glucose
Chick Embryo Extract (CEE) MP Biomedicals #092850145
B27 Life Technologies #12587-010 – 50 ×
Human recombinant IGF-I Sigma Aldrich #SRP3069 – in ddH2O+ 5%
Trehalose in PBS (1:1)
Human recombinant bFGF Peprotech – in Tris 5mM pH7.6
Retinoic acid Sigma Aldrich #R2625-10mM in DMSO
BMP-4 Peprotech #120-05 – in citric acid (pH3.0): BS
with 2mg/ml BSA (1:1)
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5-Bromo-4-chloro-3-indolyl phosphate (BCIP) solutions (Roche).
Embryos were ﬁxed in 4% PFA for 20min when they reached the desired
state and dehydrated in MeOH to be stored at −20 °C. Images of whole
mount embryos were taken using an Axioskop2 (Zeiss) microscope
equipped with Axiovision software, and a region between somites
10–15 was dissected and embedded in blocks of gelatin for transverse
sectioning at 20 µm using a cryostat. Detailed information of antibodies
can be found in Supplementary Table 2.
Similarly, crestospheres were ﬁxed in 4% PFA for 30min at RT or
overnight at + 4 °C and washed in DEPC-PBT. Samples were then
gradually dehydrated by bringing them to 100% MeOH and kept at
−20 °C for a minimum of 2 h. In situ hybridization was performed as
described above (Acloque et al., 2008). Avian DIG-labelled hybridiza-
tion probes for SOX10, SOX9, PAX7, SNAI2, FOXD3 and SOX2 and
were cloned by using chicken cDNA as previously described
(Khudyakov and Bronner-Fraser, 2009).
2.6. Cryosections and immunohistochemistry
Crestospheres were ﬁxed in 4% paraformaldehyde for 15min at RT
and washed three times in TBS-T (TBS + Ca2+ supplemented with 0.1%
Triton-X). For embedding, spheres were incubated in a sucrose
gradient (5% sucrose for 10min and 15% sucrose for 10min, all at
RT) followed by incubation in 7.5% gelatin over night at 37 °C, then
placed into a mold and snap frozen. Embedded spheres were cryosec-
tioned at 12 µm.
For immunoﬂuorescence, whole spheres were blocked in 10% goat
serum in TBS-T or 10% donkey serum in PBS-T for 4 h at RT and
washed twice in TBS-T for 30min before incubation with primary
antibody (mouse anti-PAX7, Hybridoma Bank) diluted in block solu-
tion over night at + 4 °C. After two times washing for 30min in TBS-T,
crestospheres were incubated with secondary antibody (anti-mouse
Alexa Fluor) and DAPI (diluted in blocking solution) for 4 h at RT.
SOX9 immunostaining was performed on sections following the same
protocol followed by anti-rabbit Alexa Fluor for 1 h at RT as secondary
antibody. Slides were washed in TBS-T and mounted. Detailed
information of antibodies can be found in Supplementary Table 2.
2.7. Self-renewal / primary sphere assay
Crestospheres were dissociated into single cells using Accutase
(Sigma Aldrich; incubation at 37 °C for 40min with one minute of
pipetting every 10min), and one (1) or ﬁve (5) cell(s) were manually
picked using a p10 pipette tip under the microscope. Single cells were
transferred to 96-well plates prepared with 100 μl of NC medium
supplemented with RA and BMP-4. New NC medium supplemented
with RA and BMP-4 (Vtotal = 100 μl) was added every 2–3 days to avoid
wells to dry out. The absolute number of spheres formed in each well
was quantiﬁed manually under the microscope, where clusters of more
than ten cells were counted as spheres. Cultures initiated with one cell/
well were counted after one week followed by another counting after
the second week without dissociation of the spheres during the culture
period. The second week thus reﬂected the number of secondary
spheres formed from the primary spheres. Spheres seeded in a dilute
concentration of ﬁve cells per well were counted after one week of
culture. Results obtained for 1 cell/well conditions (T = 1 week and
T = 2 weeks) were derived from three individual crestosphere cultures
(n = 3) and ﬁve wells were analyzed per culture (n = 15 wells in total).
Similarly, results obtained for 5 cells/well conditions were derived
from two individual crestosphere cultures (n = 2) and n = 5 wells were
analyzed per culture (n = 10 wells in total).
2.8. Diﬀerentiation assay
Crestospheres were mechanically dissociated into smaller clusters
and seeded on coated cover slips (0.1 μg/μl poly-D-lysine, BD
Biosciences). Crestospheres were incubated for 7 days in
DMEM+ 1% fetal calf serum (FCS) (α-SMA; GFAP; RUNX2) or
DMEM+ 1% N2 + 1% FCS+ 1% CEE (BLBP; TUJ1). Medium was
changed once during the incubation time. Cells were ﬁxed in 4% PFA
for 15min at RT and cover slips blocked in 5% Goat serum+ 0.3%
Triton-X in PBS-DEPC (α-SMA; TUJ1; RUNX2) or 0.3% Triton-X in
PBS/3% BSA (GFAP; BLBP) for 1 h at RT. Before incubation with BLBP
antibody, antigen retrieval was performed by brief boiling in 10mM
trisodium citrate pH6. Incubation with primary antibodies was per-
formed at + 4 °C over night. After washing in PBS, incubation with
secondary antibodies diluted in corresponding blocking solution was
performed in combination with DAPI (Dako) for 1 h at RT. Detailed
information of antibodies can be found in Supplementary Table 2.
2.9. Lentiviral transduction
Crestospheres were dissociated into single cells / small clusters
using Accutase (Sigma Aldrich; incubation at 37 °C for 20–40min with
one minute of pipetting every 10min) and seeded at high density in
150 μl culture medium in 24-well plates. Cells were directly transduced
with increasing concentrations of pCIG3-GFP (pCMV-IRES-GFP ver-
sion 3, kind gift from Felicia Goodrum (Addgene plasmid # 78264)
(Caviness et al., 2014)). Medium was changed twice a day for four
consecutive days. GFP expression was analyzed 96 h post-transduction
using an Olympus inverted ﬂuorescence microscope. Virus titers were
optimized and calculated using sphere growing neuroblastoma patient-
derived xenograft cells (Persson et al., 2017) due to the diﬃculty in
obtaining pure single cell suspensions of trunk crestosphere cultures.
Two titers were tested; 2.1*10^8 TU/ml and 2.3*10^8 TU/ml; TU,
transducing units.
2.10. Resources
Essential resources and reagents are listed in Key Resource Table.
3. Results & discussion
3.1. Optimization of the correct trunk premigratory axial level
Cranial crestospheres grow as three-dimensional spheres under
conditions optimized for neural tubes from chick embryos as well as
human embryonic stem (ES) cells; these spheres retain their self-
renewal capacity and multipotency for up to seven weeks in culture
(Kerosuo et al., 2015). Here, we sought to devise modiﬁcations that
would enable growth and maintenance of premigratory neural crest
cells from more posterior axial levels to provide a tool for studies on
trunk neural crest stemness as well as trunk-derived neurocristopa-
thies.
To ensure that the proper stage from which to derive crestosphere
cultures was used, we performed in situ hybridization on whole mount
embryos using neural crest markers SOX10, FOXD3, PAX7, SOX9,
SNAI2 and the neuroepithelial marker SOX2 (Fig. 1A-F). As expected,
the endogenous expression patterns showed that the trunk neural crest
was premigratory at the level adjacent to somites 10–16 in stage
HH13-/14 embryos.
We tested our cranial crestosphere protocol on dissociated cell
clusters of trunk neural tubes derived from chick embryos at several
stages (HH10 +, HH12, HH13/14), and conﬁrmed that 17–21 somite
stage (HH13/14) embryos was the optimal developmental stage for
trunk crestosphere culture establishment (Fig. 2A). With HH13/14
embryos, spheres formed rapidly after tissue dissociation and ex-
panded accordingly during in vitro culture, whereas trunk cresto-
spheres derived from HH10 + or HH12 embryos grew slower and
expressed lower levels of neural crest markers (data not shown).
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3.2. Trunk neural crest cells do not survive in conditions optimized
for cranial crestospheres
Although it was initially possible to establish trunk crestospheres
under culture conditions optimized for cranial crestospheres (Kerosuo
et al., 2015), trunk crestospheres failed to thrive and expand long term.
All cultures resulted in less than 25 spheres each during the entire
three-week culture period (n = 4). In comparison, all three simulta-
neously established cranial cultures produced 100 + spheres (n = 3).
Given the known importance of retinoic acid (RA) in poster-
iorizing the body axis as well as in caudal neural crest development
(Kudoh et al., 2002; Martinez-Morales et al., 2011; Retnoaji et al.,
2014), we increased the amount of RA in the culture medium from
60 nM (Kerosuo et al., 2015) to 180 nM. Visual observation of sphere
growth suggested that 180 nM of RA was optimal for successful
expansion of trunk-derived crestospheres. All cultures resulted in
more than 50–100 spheres (n = 6). Despite the additional supply of
RA, trunk-derived crestosphere cultures continued to grow more
slowly than cranial-derived cultures. We therefore optimized the
starting culture volume by further decreasing it by 25% from 2ml
used for cranial crestospheres (Kerosuo et al., 2015) (n = 7) to 1.5 ml
NC medium (n = 8). This decrease in starting culture volume had a
Fig. 1. Endogenous expression of premigratory neural crest markers in the posterior axial levels. (A-F) Whole mount in situ hybridization of HH13–14 embryos. (A’-F’) Inserts
showing the neural tube at the respective somite level that was dissected for trunk crestosphere cultures. (A’’-F’’) Transverse sections of the neural tubes at the level that was used for
trunk crestosphere cultures. nt, neural tube; n, notochord; s, somite; pmnc, premigratory neural crest.
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positive impact on trunk crestosphere expansion, suggesting that the
crestospheres condition their own medium by producing additional
essential growth factors. The number of spheres in each culture
reached ~50 in less than 48 h (n = 3), equivalent to that observed for
cranial-derived spheres under optimal cranial crestosphere condi-
tions. In similarity to previously established cranial crestospheres
(Kerosuo et al., 2015), trunk crestosphere cultures grew and
expanded in vitro for 6–7 weeks, after which they were still viable
but virtually stopped to proliferate.
3.3. Trunk crestospheres are enriched for neural crest cells
Next, we performed in situ hybridization to test expression of
neural crest markers in our established sphere cultures. Trunk cresto-
spheres displayed strong expression of the early neural crest speciﬁer
genes SOX10 and SOX9 (Fig. 2B and C, respectively), that continue to
be expressed in the migratory cells after EMT, which conﬁrmed
enrichment of neural crest cells. We applied immunohistochemistry
to examine expression of PAX7, another early neural crest marker that
starts to be expressed already during induction at the neural plate
border, and SOX9. Furthermore, even though both PAX7 and SOX9 are
expressed outside the neural crest domain in the neighboring tissues
(Fig. 1C’ and D’, respectively) their expression pattern is overlapping
only in the neural crest. Therefore, we performed dual immunostaining
to further conﬁrm the neural crest identity of trunk crestospheres. As
expected (Kerosuo et al., 2015; Lignell et al., 2017), the vast majority of
cells expressed both markers even though the intensity of the expres-
sion varied from cell to cell (Fig. 2D). Quantiﬁcation of PAX7 + and
SOX9 + cells showed that in average 54% (PAX7) and 78% (SOX9) of
crestospheres were positive for these markers (Fig. 2E). Importantly,
the Pax7 antibody in general gave a weaker staining than the Sox9,
which may slightly impact the quantiﬁcation. We also used high
magniﬁcation imaging on cryosections, which conﬁrmed the hetero-
genous expression pattern with some cells expressing only one or none
of the markers, whereas others expressed both (Fig. 2F). Finally, we
used in situ hybridization to detect expression of SOX2 (Fig. 2G). In
Fig. 2. Trunk crestospheres are enriched for neural crest marker expression. (A) Trunk crestospheres cultured without or with BMP-4 in vitro grow in a similar fashion. (B) In situ
hybridization for SOX10 on trunk crestospheres. (C) In situ hybridization for SOX9 on trunk crestospheres. (D) PAX7 (green) and SOX9 (red) double immunostaining of a trunk
crestosphere shows that the majority of cells express both markers. Please note that the large bright green spots are not speciﬁc staining. (E) Quantiﬁcation of PAX7 and SOX9 positive
cells, respectively. Four individual spheres (n = 4) were counted containing 1415 cells in total. (F) High magniﬁcation from a double PAX7 (red) and SOX9 (green) immunostained
cryosection. Arrows indicate double positive cells, arrowheads indicate SOX9 single positive cells and asterisks indicate PAX7 single positive cells. (G) In situ hybridization for SOX2 on
trunk crestospheres.
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concordance with neural crest cells expressing low levels of SOX2
(Kerosuo et al., 2018; Roellig et al., 2017), we as well detected weak to
moderate expression of SOX2 further conﬁrming the neuroepithelial
nature of these spheres (Fig. 2G). Taken together, based on these data
we conclude that our trunk crestosphere cultures are highly enriched
for neural crest cells. However, we cannot rule out the possible
existence of some “future CNS” neuroepithelial stem cells similar to
what is observed in the developing neural tube.
3.4. Trunk-derived crestospheres consist of a combination of neural
crest stem and progenitor cells
To further characterize gene expression patterns of the trunk
crestosphere cultures, and to ensure lack of contamination from
neighboring mesodermal cells, we used quantitative RT-PCR (qPCR)
to address expression levels of neural crest markers relative to markers
that reﬂect the presence of mesodermal fates. Consistent with in situ
Fig. 3. Quantitative RT-PCR shows enriched neural crest gene expression in trunk crestospheres. (A) Relative mRNA expression of neural crest- and mesodermal- associated genes
comparing trunk crestosphere cultures (n = 3) to stage HH10 whole embryo wild type (WT) (n = 1, pool of three embryos) at 2 weeks of culture. (B) Relative mRNA levels of neural crest
and mesodermal markers in trunk crestospheres at 3.5 weeks of culture (n = 1) compared to stage HH13 whole embryo wild type (WT) (n = 1, pool of three embryos). (C) Relative
mRNA expression of neural crest-associated genes comparing trunk crestospheres cultured with (n = 3) or without (n = 3) BMP-4. (D) Relative mRNA expression levels of trunk neural
crest-enriched genes comparing trunk crestospheres cultured with BMP-4 (n = 3) to stage HH10 whole embryo wild type (WT) (n = 1, pool of three embryos) and cranial crestosphere
cultures (n = 4). (A-D) Data is presented as mean of n = 3–4 ± SEM (from biologically independent repeats) or n = 1 ± SD (from technical triplicate), and signiﬁcance between trunk
crestospheres cultured with or without BMP-4 (C) and statistical signiﬁcance for trunk and cranial crestosphere cultures (D) was calculated using two-sided student's t-test; *p < 0.05,
**p < 0.01.
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hybridization results, trunk crestospheres cultured for 2 weeks
(Fig. 3A) or one month (Fig. 3B) display increased expression of neural
crest markers SOX10 (Fig. 3A-B) and the premigratory marker FOXD3
that becomes downregulated directly after EMT ((Lignell et al., 2017),
Fig. 3A). We also detected increased expression levels of the “migratory
only” neural crest marker B3GAT1 (Fig. 3A; encoding the enzyme
required for formation of the HNK1-epitope; expressed in avian neural
crest), as compared to expression levels in whole wild-type (WT)
embryos. These results show that trunk crestospheres consist of a
mixture of cells at multiple neural crest developmental stages instead of
purely premigratory neural crest cells, as shown in many spheroid
cultures of diﬀerent stem cell types (Jensen and Parmar, 2006;
Piscitelli et al., 2015). Meanwhile, the relative expression levels of
mesodermal genes MYOD1 and T (T brachyury transcription factor)
were low (Fig. 3A-B). These results conﬁrm the primarily neural crest
identity of trunk crestospheres and rule out contamination by meso-
derm-derived cells.
3.5. Addition of BMP-4 to the culture medium promotes neural crest
maintenance and expansion
During normal development BMP-4 is secreted by the dorsal neural
tube at the premigratory stage to promote neural crest fate (Basch
et al., 2006; Hackland et al., 2017; Liem et al., 1995; Steventon et al.,
2009), and later by the dorsal aorta, providing cues for neural crest cell
migration as well as sympathoadrenal and chromaﬃn cell fate
(Unsicker et al., 2013). We therefore compared expression of neural
crest genes in trunk crestosphere cultures without (i.e. ‘normal’ NC
medium) or with BMP-4 supplement, testing whether addition of BMP-
4 could increase relative expression levels of neural crest genes. By
visual inspection, the crestospheres grew similarly with or without
BMP4 (Fig. 2A). However, expression of the early neural crest marker
genes TFAP2B and SNAI2 increased (Fig. 3C). We also detected
increased levels of NGFR, a marker expressed later by migrating and
maturing peripheral neurons (Heuer et al., 1990) (Fig. 3C), possibly
also causing fate bias towards peripheral nervous system cell types. We
conclude that BMP-4 further enriched neural crest fate in the cultures
and should be routinely added to the optimized trunk crestosphere
culture medium (Table 1). Altogether, we show that increased con-
centrations of RA are crucial for trunk crestosphere culture expansion
(Table 1), and that BMP-4 enhances expression of at least some neural
crest marker genes (Fig. 3C).
3.6. Trunk-derived crestospheres are enriched for trunk neural crest
genes
Next, we performed qPCR to determine relative expression of
recently characterized genes associated with trunk neural crest
(Murko et al., 2018). We observed enriched expression levels of these
genes in trunk crestospheres as compared to cranial crestospheres,
reﬂecting the maintenance of posterior axial levels in the trunk
crestosphere cultures (Fig. 3D).
3.7. Trunk crestosphere-derived cells are multipotent
To ensure that our established trunk crestospheres maintain their
multipotent stem-like nature in culture, we plated the crestospheres in
diﬀerentiation promoting conditions for one week. Microphotographs
revealed substantial diﬀerences in cellular morphology (Fig. 4A),
considerably aberrant from the growth pattern of crestospheres in
NC medium (Fig. 2A), but also intercellularly within the diﬀerentiated
cell population. To determine which cellular lineages trunk cresto-
sphere-derived cells committed to, we used lineage speciﬁc antibodies
and, as expected (Vega-Lopez et al., 2017), detected smooth muscle (α-
SMA) (Fig. 4B), and peripheral neurons (TUJ1) (Fig. 4C) and glial
cells/astrocytes (GFAP, BLBP) (Fig. 4D-E, respectively). Surprisingly,
we also detected a few cells expressing the cartilage marker RUNX2, a
feature of the cranial neural crest (Fig. 4F), perhaps reﬂecting a
diﬀerence between in vitro and in vivo potential. These results
demonstrate that trunk crestospheres maintained potential for several
lineages under the deﬁned stem cell cultures, and thus indicate
maintenance of multipotency.
3.8. Single trunk-derived crestosphere cells self-renew in culture
Another important stem cell-associated trait is the ability to self-
renew. For this, we performed primary sphere assays over the course of
two weeks. Quantiﬁcation of the number of formed spheres (cell
clusters containing ≅ or > 10 cells) showed that trunk crestosphere-
derived single cells were able to self-renew in culture in single cell wells
(Fig. 4G) and when seeded sparsely in multi-cell wells (5 cells/well,
Fig. 4H). We allowed cells seeded in single cell wells to continue to self-
renew for an additional week (t = 2 weeks in total). As expected, the
number of spheres increased over time as shown by higher sphere
numbers counted after the second week (Fig. 4I-J). These results were
conﬁrmed by a strong correlation at a population level (R = 0.81;
Fig. 4K).
3.9. Trunk crestospheres can be eﬃciently transduced using lentiviral
vectors
Genetic manipulation of crestospheres is one potential application
for analysis on downstream eﬀects of genes of interest (Dupin et al.,
2018; Kerosuo and Bronner, 2016). However, our previous attempts
using siRNAs have demonstrated low transfection eﬃciency (Kerosuo
and Bronner, 2016). Therefore, we sought to determine whether trunk-
derived crestospheres could be eﬃciently transduced using viral
vectors to create stable phenotypes. In a proof-of-principle experiment,
we used a GFP-tagged lentiviral vector (pCMV-IRES-GFP version 3;
pCIG3) and transduced trunk crestospheres with increasing concentra-
tions of the virus. Trunk crestospheres did not display toxic side eﬀects
after viral transduction and survived well at all concentrations inves-
tigated. By analyzing GFP expression in individual spheres using live
ﬂuorescent microscopy, we observed no major diﬀerences in GFP
intensity between the diﬀerent viral concentrations tested (Fig. 4L).
To assess transduction eﬃciency, we compared EGFP expression in
regularly grown crestospheres (CTRL) and pCIG3-GFP transduced
crestosphere cultures. There was an in average 200-fold induction in
EGFP expression in transduced spheres (Fig. 4M). These results show
that trunk crestospheres can be eﬃciently transduced to create stable
genotypes, overcoming the transient and ineﬃcient nature of siRNAs.
4. Conclusions
Crestospheres are an excellent tool to study diﬀerent aspects of
neural crest stemness and diﬀerentiation (Dupin et al., 2018; Kerosuo
and Bronner, 2016; Kerosuo et al., 2015). Given the known axial level
diﬀerences in the ability of cranial and trunk neural crest cells to give
rise to diﬀerent cell types (Ayer-Le Lievre and Le Douarin, 1982;
Simoes-Costa and Bronner, 2016), here we optimized previous cranial
crestosphere conditions (Kerosuo et al., 2015) for maintenance of
trunk-derived neural crest cultures that arise from more posterior axial
levels, as illustrated in Fig. 5. Our protocol for trunk crestosphere
cultures results in enrichment of neural crest speciﬁc genes as shown
by in situ hybridization, immunostaining and qPCR, with little expres-
sion of mesodermal markers.
Considering that we have not performed quantitative analysis at a
single cell level, relative expression levels provide only a guideline for
the enriched cell types. The beneﬁt of evaluating sphere identity with
neural crest markers like FOXD3, SOX10 and SNAI2 is that they are
not expressed elsewhere in the neural tube or the surrounding
mesoderm in the embryo. Therefore, their expression can be directly
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Fig. 4. Trunk crestospheres self-renew and are multipotent. (A)Microphotographs of trunk crestosphere-derived diﬀerentiated cells following adherent growth on poly-D-lysine coated
plates and diﬀerentiation-inducing medium. (B-F) Immunoﬂuorescent staining of markers representing smooth muscle (α-SMA, B), peripheral neuron (TUJ1, C), glial/astrocyte (GFAP [D],
BLBP [E]) and cartilage (RUNX2, F) lineages following adherent growth on poly-D-lysine coated cover slips and diﬀerentiation-inducing medium. (G) Self-renewal capacity measured as number of
spheres derived from single cells seeded as 1 cell/well. Number of spheres were quantiﬁed after one week of culture from 15 wells in total (ﬁve wells each from three individual crestosphere
cultures). (H) Self-renewal capacity measured as number of spheres derived from single cells seeded at 5 cells/well. Number of spheres were quantiﬁed after one week of culture from 10 wells in
total (ﬁve wells each from two individual trunk crestosphere cultures). (I) Self-renewal capacity measured as number of spheres derived from single cells seeded as 1 cell/well (G). Number of
spheres was quantiﬁed after two weeks of culture; n=15 wells from n=3 trunk crestosphere cultures. (J) Primary sphere formation of each individual single cell seeded at 1 cell/well density
assessed after one and two weeks of culture, displaying that each and every cell possesses self-renewal capacity. (K) Primary sphere formation of each individual single cell seeded at 1 cell/well
density assessed after one and two weeks of culture, based on population level. Pearson correlation coeﬃcient, R=0.81. (L) GFP expression in individual trunk crestosphere cells transduced with
diﬀerent concentration of the virus shows similar transduction eﬃciency at all conditions. TU; Transducing Units. (M) Relative mRNA levels of EGFP comparing pCIG3-GFP transduced trunk
crestosphere cultures and their non-transduced counterparts (CTRL). Data is presented as mean of n=2 ± SEM, and signiﬁcance was calculated using two-sided student's t-test; * *p < 0.01.
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interpreted as neural crest cell fate. We also used double immunostain-
ing of PAX7 and SOX9 to conﬁrm the neural crest identity in our trunk
crestospheres since these markers show overlapping expression only in
the neural crest. Based on the expression of neuroepithelial SOX2, a
marker that is also expressed in the neural crest at low levels (Kerosuo
et al., 2018), we can however not exclude the possibility of the existence
of some dorsal neural stem cells, a cell type that in the embryo
naturally occurs very close to neural crest cells in the dorsal neural
tube (Lignell et al., 2017). Many of the known neural crest factors (e.g.
SOX10, SOX9, AP2alpha, SNAI2 and PAX7) are expressed from
premigratory to late migratory stages, and their expression does not
automatically reﬂect a certain developmental time point. However,
other markers, such as FOXD3 (premigratory to very early stage
migration) or HNK1 (encoded by B3GAT1) and NGFR (migratory)
are more speciﬁc and can be used to distinguish between these diﬀerent
stages. Based on our data, we conclude that the trunk crestosphere
cultures are a mixture of stem- (premigratory) as well as more
diﬀerentiated progenitor cell types of trunk axial level neural crest.
In addition, based on enriched expression of a set of genes shown by a
recent study to be upregulated in trunk neural crest by performing a
trunk-speciﬁc SOX10-enhancer based RNAseq screen (Murko et al.,
2018), the expression proﬁle of our spheres demonstrates a dominance
of trunk axial level as compared to cranial crestospheres.
Analysis of trunk crestosphere gene expression at two and four
weeks of culture suggests that the premigratory neural crest cell state
was maintained for at least one month of culture. Considering that the
neural crest is a transient population of stem cells that is maintained in
the premigratory stage only for less than a day, we conclude that the
conditions used in our trunk cultures maintain neural crest stem cell
potential for extended periods of time.
We show that trunk crestospheres are self-renewing neuroepithelial
cells enriched for neural crest. Furthermore, diﬀerentiation assays
show that trunk crestospheres are multipotent with the ability to
diﬀerentiate into multiple lineages including neurons, glia, smooth
muscle (Bittencourt et al., 2013), and to our surprise, also a few cells of
the cartilage lineage. Since all the cultures were originated from trunk
axial levels that do not form neural crest-derived cartilage in the
embryo, this data may reﬂect a diﬀerence between the in vitro and in
vivo potential. Alternatively, the potential can be equal in both, but the
trigger for the inhibition of the cartilage potential present in the
embryo may be missing from our cultures. Finally, even though we
have demonstrated that crestosphere conditions do not support
maintenance of a mesodermal fate, low levels of contamination
followed by successful maintenance of some somite-derived cells
cannot be ruled out, and veriﬁcation of this interesting ﬁnding thus
requires further proof.
While providing a useful tool for studying normal neural crest
development, trunk crestosphere cultures also provide a novel approach
for advancing research on neural crest-derived diseases and malignan-
cies, including neuroblastoma, paraganglioma and pheochromocytoma,
as well as syndromes like Congenital Central Hypoventilation Syndrome
(CCHS), Familial Dysautonomia (FD), or von Hippel-Lindau Syndrome
(Huber et al., 2018; Tsubota and Kadomatsu, 2018; Zhang et al., 2010).
Given the ability to perform viral transduction, trunk crestospheres
further promise to provide insight into the molecular mechanisms that
govern normal development as well as diseases derived from the more
posterior parts of the embryo.
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